scispace - formally typeset
N

Nina Schumacher

Researcher at University of Lübeck

Publications -  10
Citations -  189

Nina Schumacher is an academic researcher from University of Lübeck. The author has contributed to research in topics: Cyclosporin a & Ex vivo. The author has an hindex of 4, co-authored 10 publications receiving 175 citations.

Papers
More filters
Journal ArticleDOI

Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients

TL;DR: This data indicates that a combination of immunoadsorption and rituximab with daily use of high‐dose oral corticosteroids and azathioprine/mycophenolate mofetil may induce a rapid and durable remission in severe, treatment‐resistant pemphigus.
Journal ArticleDOI

Delayed Cytokine mRNA Expression Kinetics after T-Lymphocyte Costimulation: A Quantitative Measure of the Efficacy of Cyclosporin A-based Immunosuppression

TL;DR: A delayed increase in cytokine mRNA expression during T-cell costimulation may represent a sensitive effect of immunosuppression and the parameter "area of cytokineRNA expression over time", which should include absolute cytokine RNA values at two different time points of mRNA kinetics is suggested.
Journal ArticleDOI

Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect.

TL;DR: The results suggest an individual degree of calcineurin inhibitor sensitivity of activated whole-blood lymphocytes based on IL-2 mRNA expression is possible in patients undergoing tacrolimus or CsA monotherapy before living-donor kidney transplantation.
Journal ArticleDOI

Individual variability in cyclosporin A sensitivity: the assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytes.

TL;DR: This article found that cyclosporin A (CsA) effects might be helpful for optimizing immunosuppressive treatment after allogeneic organ transplantation in individual patients, as rejection can occur despite the existence of CsA blood levels within therapeutic ranges.
Journal ArticleDOI

Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita.

TL;DR: In this article, the authors defined the clinical features and treatment responses of Epidermolysis bullosa acquisita (EBA) and compared the prevalences of IgA EBA anti-BP180-driven LABD and classic IgG-mediated EBA in an autoimmune diagnostic laboratory database.